High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.
- DOI
- 10.1128/aac.48.6.2308-2313.2004
- Published
- 2004 Jun
- Container
- Antimicrobial agents and chemotherapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1128/aac.48.6.2308-2313.2004,
title = {High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.},
author = {Cartelle M and del Mar Tomas M and Molina F and Moure R and Villanueva R and Bou G},
year = {2004},
journal = {Antimicrobial agents and chemotherapy},
doi = {10.1128/aac.48.6.2308-2313.2004},
url = {https://doi.org/10.1128/aac.48.6.2308-2313.2004}
}RIS
TY - JOUR TI - High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. AU - Cartelle M AU - del Mar Tomas M AU - Molina F AU - Moure R AU - Villanueva R AU - Bou G PY - 2004 JO - Antimicrobial agents and chemotherapy DO - 10.1128/aac.48.6.2308-2313.2004 UR - https://doi.org/10.1128/aac.48.6.2308-2313.2004 ER -
APA
M, C., M, D. M. T., F, M., R, M., R, V., & G, B. (2004). High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.48.6.2308-2313.2004
Source records
- pubmed · retrieved 2026-09-26T23:35:36.975Z